Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | DRD4 | P21917 | 1/20 | 0.32 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.31 |
| ▸ | F11 | P03951 | 3/20 | 0.31 |
| ▸ | KLKB1 | P03952 | 3/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HTR2C | P28335 | 3/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.31 |
| ▸ | DGAT2 | Q96PD7 | 1/20 | 0.31 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30723867 | 0.88 | NPC1 (0.33) | NPC1RAB9ADRD4F11KLKB1 | |
| SCHEMBL30723941 | 0.87 | NPC1 (0.34) | NPC1RAB9ACRHR1F11KLKB1 | |
| SCHEMBL30723779 | 0.84 | NPC1 (0.33) | NPC1RAB9AF11KLKB1ALDH1A1 | |
| SCHEMBL30723843 | 0.76 | — | — | |
| SCHEMBL30723926 | 0.74 | EHMT2 (0.32) | EHMT2 | |
| SCHEMBL30723890 | 0.74 | ESR1 (0.36) | — | |
| SCHEMBL30723920 | 0.74 | — | — | |
| SCHEMBL30723815 | 0.73 | — | — | |
| SCHEMBL30723912 | 0.73 | — | — | |
| SCHEMBL25917542 | 0.72 | CYP4F2 (0.34) | ALDH1A1DGAT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024006776-A1 | ESTROGEN RECEPTOR ALPHA DEGRADERS AND MEDICAL USE THEREOF | RELAY THERAPEUTICS, INC. (US) | 2024-01-04 | — | — | WO | disclosed |